FDA guidance
Q2(R2) Validation of Analytical Procedures
FDA guidance · Final · issued Mar 6, 2024
Key facts
| Title | Q2(R2) Validation of Analytical Procedures |
|---|---|
| Status | Final |
| Issue date | Mar 6, 2024 |
| Center | Center for Drug Evaluation and Research |
| Issuing office | Center for Drug Evaluation and Research, Office of Regulatory Policy |
| Communication type | Guidance Document |
| Regulated product | Drugs |
| Docket number | FDA-2022-D-1503 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents